FDAFDA · Food and drugs·Recall number D-0594-2026
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Published June 24, 2026 · Recall initiated: May 27, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ARIPIPRAZOLE
- Manufacturer
- Ajanta Pharma USA Inc
- Distributor
- U.S. Nationwide
- UPC
- 0327241051036
- Lot
- Lot: PA00805, expires: 01/31/2029
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.